Study of Immune Response in HPV-Positive Head and Neck Cancer in Mice
Author Information
Author(s): Franziska Oliveri, Linda Neher, Ronja Pscheid, Isabel Sewald, Sowmya Gowdavally, Annika C. Betzler, Jaqueline Hallitsch, Jens Greve, Simon Laban, Sebastian Schmid, Thomas K. Hoffmann, Patrick J. Schuler, Cornelia Brunner
Primary Institution: Ulm University Medical Center
Hypothesis
Can a mouse model of HPV-positive head and neck squamous cell carcinoma (HNSCC) help understand the immune response and identify new therapeutic targets?
Conclusion
The study shows that the mouse model mimics human HPV-positive HNSCC and can be used to study anti-tumor immune responses.
Supporting Evidence
- The mouse model showed strong adaptive immune responses similar to those observed in human patients.
- T cells in both mice and humans expressed high levels of immunosuppressive markers.
- B cell responses were significantly elevated in tumor-bearing mice.
- Immunoregulatory pathways were enhanced in both the mouse model and human samples.
- CD39 and CD73 expression was significantly higher in tumor-infiltrating T cells.
- Similar patterns of immune checkpoint expression were found in human HPV-positive HNSCC.
Takeaway
Researchers created a mouse model to study how the immune system responds to a type of throat cancer caused by a virus, which could help find new treatments.
Methodology
The study involved creating a mouse cell line overexpressing HPV16 oncogenes and analyzing immune responses after tumor growth.
Limitations
The study was limited to a short time frame of tumor growth, which may not fully capture the immune response.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website